Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Clinical trial NCT04069273 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04069273
- Sponsor
- Harry H Yoon
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2026-08-11
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.